PLASMA EXTRACTION DEVICE AND ASSOCIATED PROCESS
The plasma extraction device addresses the limitations of existing methods by using a membrane and capillary system for efficient, rapid, and user-friendly plasma extraction, ensuring minimal cell contamination and consistent volume delivery.
Patent Information
- Application Number
- FR2023004985
- Authority / Receiving Office
- FR · FR
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-19
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing methods for extracting plasma from whole blood, such as centrifugation and decantation, are complex, bulky, expensive, and unsuitable for daily use, requiring significant blood volumes and medical expertise, with potential disruption of cell layers and prolonged processing times.
A plasma extraction device comprising a membrane, capillary, and ejection member, utilizing a membrane with an inclination and specific material properties to facilitate filtration and delivery of a precise plasma volume, optimized for low blood volumes and user-friendly operation.
Enables efficient, rapid, and repeatable plasma extraction with minimal cell contamination, suitable for daily use by unqualified individuals, delivering a consistent plasma volume within minutes.
Abstract
Description
Title of the invention: PLASMA EXTRACTION DEVICE AND ASSOCIATED METHOD FIELD OF THE INVENTION
[0001] The present invention relates to a device for extracting plasma from a blood sample. The invention also relates to a method for extracting plasma using such a device. STATE OF THE ART
[0002] Whole blood is composed of approximately 55% plasma and 45% cells such as red blood cells, white blood cells, or platelets. Plasma is used in many applications to measure specific biological markers such as glucose levels or hematocrit.
[0003] For this purpose, the separation of the plasma is a critical step. Indeed, the separation must be as efficient as possible to limit as much as possible the presence of cells remaining in the plasma and also to limit cell lysis debris. Indeed, these elements can influence the measurement of the different biological markers.
[0004] Conventionally, plasma is extracted from blood by centrifugation. Centrifugation is a process of separating compounds from a mixture based on their density difference by subjecting them to centrifugal force. Thus, after centrifugation, the plasma remains on the surface, while the cells migrate downwards. The plasma is then removed using a pipette, but a small amount near the boundary between the plasma layer and the cell layer is left as a precaution. Removing all the plasma carries the risk of disturbing the cell layer, which affects subsequent processes.
[0005] However, centrifuges are complex, bulky and expensive devices.
[0006] Alternatively, it is possible to separate the plasma from the whole blood by decantation, but this method takes a very long time to implement before obtaining a satisfactory result.
[0007] Furthermore, these solutions require large quantities of blood to be effective, so they are not suitable for daily use, such as for diabetics, who must test their blood sugar several times a day.
[0008] Thus, the problem that the invention seeks to solve is to provide a simpler and less expensive device allowing daily use, not requiring any particular medical expertise. SUMMARY
[0009] The invention solves this problem by proposing a device for extracting plasma from a blood sample, the device comprising: - a membrane configured to extract plasma from the blood sample, the membrane having an upper surface arranged to receive the blood sample and a lower surface, - a capillary comprising: an inlet arranged opposite the lower surface of the membrane to receive the plasma, and an outlet open to an exterior of the extraction device, the capillary being configured to transport the plasma from the inlet to the outlet along a trajectory, - an ejection member actuable by an operator and configured to eject a volume of plasma located in the capillary through the outlet when said ejection member is actuated, the extraction device further comprising a T-junction to which the ejection member is connected, perpendicular to the capillary, the plasma volume being between the T-junction and the outlet.
[0010] In other words, the invention relates to a device for both separating plasma from whole blood by filtration using the membrane, and also delivering a predetermined volume of plasma required to perform a test for a biological marker. The invention is particularly suitable for filtering and delivering small volumes. Typically, the volume of blood deposited on the membrane is between 50 pL and 100 pL and the volume of plasma ejected at the outlet of the device can vary between 5 pL and 15 pL. The volume of plasma actually ejected at the outlet by the device advantageously has a variability of less than 2% of the desired plasma volume.
[0011] Furthermore, the device can advantageously be used by an unqualified person such as the patient himself. Indeed, the ejection of the predetermined quantity of plasma requires only a simple pressure on the ejection member so that the same volume is systematically ejected.
[0012] Advantageously, the device may be designed to limit the time between the deposition of whole blood on the membrane and the moment when it is possible to eject the desired volume of plasma.
[0013] For this purpose, according to a first embodiment, the membrane comprises a front edge and a rear edge, the membrane being inclined at an angle of between 5° and 10° from the front edge towards the rear edge relative to a longitudinal plane of the capillary.
[0014] The inclination of the membrane advantageously makes it possible to increase the filtration speed of the whole blood by maximizing the capillary effect.
[0015] According to another embodiment, the capillary is made of a material having a wetting angle of less than 60°, preferably less than 57° with the plasma.
[0016] According to the invention, the wetting angle corresponds to the angle defined between a straight line belonging to the surface of the material and a tangent passing through the point of intersection between the surface of the material and a drop of plasma deposited on the surface of the material, and which intersects the surface of the drop. A wetting angle of less than 60° advantageously makes it possible to maximize the flow speed of the plasma in the capillary so that it fills as quickly as possible the portion of the capillary calibrated to eject the desired volume of plasma, i.e. the portion of the capillary located between the T-junction and the outlet.
[0017] According to another embodiment, the capillary has a defined height between the inlet and the outlet of less than 150 pm. Indeed, it has been found that a greater capillary height tends to reduce the flow rate of the plasma in the capillary.
[0018] In practice, a combination of these embodiments allows the user to be able to eject the plasma after a period of between 1 and 5 minutes after the blood has been deposited on the membrane.
[0019] Advantageously, the outlet is configured to be positioned in direct contact with an absorbent surface, such as for example a receiving surface of a device for testing a biological marker. Indeed, it has been noted that without direct contact, the plasma tends to remain attached to the outlet of the plasma extraction device, which leads to an increase in the variability of the volume of plasma delivered and consequently lower repeatability.
[0020] In practice, the ejection member is configured to provide a volume of fluid in the capillary at the T-junction. This volume of fluid makes it possible to induce a movement towards the outlet of the plasma volume located between the T-junction and the outlet. The volume of fluid provided is adapted to the quantity of plasma to be ejected. Advantageously, the volume of fluid is at least three times greater than the volume of plasma.
[0021] According to one embodiment, the fluid supplied by the ejection member is air.
[0022] Furthermore, according to another embodiment, the ejection member is an elastically deformable element, actuable by finger.
[0023] In practice, the T-junction has a volume less than 0.2% of the plasma volume. This geometry of the T-junction makes it possible to limit the variability of the ejected plasma volume. Indeed, the plasma volume contained in the T-junction presents a risk of remaining blocked in the T-junction or of rising towards the membrane. By limiting the volume of the T-junction, these risks are thus limited.
[0024] In a particular embodiment, the extraction device in which the ca pillaire has a capillary bottom, two capillary lateral surfaces extending opposite each other from the capillary bottom and a capillary upper surface extending between the capillary lateral surfaces opposite the capillary bottom, and in which the ejection member comprises an actuating element and a channel having a channel bottom, two channel lateral surfaces extending opposite each other from the channel bottom and a channel upper surface extending between the channel lateral surfaces opposite the channel bottom, the extraction device consisting of at least: - a support layer comprising the capillary bottom and the channel bottom, - a first layer superimposed on the support layer and comprising the lateral capillary surfaces and the lateral channel surfaces, - a second layer superimposed on the first layer and comprising the upper surfaces of the capillary and the channel, a first location configured to receive the membrane and a second location configured to receive the actuating element of the ejection member.
[0025] The present disclosure also provides a method of manufacturing an extraction device as defined in this latter particular embodiment, the manufacturing method providing for: - superimpose and secure the first layer to the support layer, - superimpose and secure the second layer to the first layer, - position the membrane in the first location of the second layer, and the actuating element of the ejection member in the second location of the second layer.
[0026] According to another aspect, the invention relates to a method of extracting plasma from a blood sample via a device as described above, the method comprising the steps of: - place a blood sample on the membrane so as to obtain plasma in the capillary, and - actuating the ejection member to eject a volume of plasma located in the capillary through the outlet when said ejection member is actuated, the volume of plasma being between the T-junction and the outlet. DESCRIPTION OF FIGURES
[0027] Other objects and advantages of the invention will appear on reading the description of the embodiment, given by way of purely illustrative and non-limiting example, made in relation to the appended drawings, in which:
[0028] [Fig.l] is a top view of the plasma extraction device according to one embodiment of the invention,
[0029] [Fig.2] is an exploded perspective side view of the device of [Fig.l],
[0030] [Fig.3] is a top view of the T-junction of [Fig.l], and
[0031] [Fig.4] is a block diagram of the method of implementing the device of [Fig.l] ILLUSTRATIVE EMBODIMENTS OF THE INVENTION
[0032] As illustrated in [Fig.l], the plasma extraction device 100 is in the form of a cartridge 11 of substantially parallelepipedal shape, with a length of between 5 cm and 10 cm, a width of between 1 cm and 5 cm and a thickness of between 0.1 cm and 0.5 cm. The cartridge 11 is made of a semi-transparent or transparent material so that the user can assess the progress of the plasma filtration and the location of the filtered plasma. Thus, preferably, the cartridge is made of a transparent thermoplastic polymer such as acrylic and more specifically poly(methyl methacrylate) or PMMA.
[0033] The cartridge 11 is thus configured to allow the user to see the different elements of the device 100, namely the membrane 12, intended to receive a sample of whole blood and to separate the plasma from the cells contained in the sample of whole blood, the capillary 13, intended to conduct the plasma to the outlet 17, the T-junction 14 located along the length of the capillary 13 and the ejection member 18.
[0034] For this purpose, the upper surface of the cartridge 11 has an opening located near an upper end of the cartridge 11. This opening allows access to the membrane 12 which is housed in the opening. The opening may be circular in shape with a diameter of between 0.5 cm and 1.5 cm.
[0035] The cartridge 11 also has an opening at the lateral edge of the end opposite that having the membrane 12. It is through this opening that the capillary 13 emerges.
[0036] By transparency, it is possible to observe the capillary 13 which is arranged in the body of the cartridge 11. It is in particular possible to observe the filling of the capillary 13 by the plasma.
[0037] It is also possible to observe the T-junction 14 and the fluid connection which connects the capillary 13 to the ejection member 18. Membrane 12
[0038] The membrane 12 according to the invention has an upper surface and a lower surface.
[0039] The whole blood sample is applied to the upper surface. The blood migrates through the membrane 12 from the upper surface to the lower surface through pores configured to block solid elements contained in the blood. such as red blood cells, white blood cells, platelets, without breaking the cell membrane.
[0040] Preferably, the membrane 12 has a total thickness of between 245 pm and 315 pm, preferably between 260 pm and 300 pm. The membrane 12 has a porosity gradient from the upper surface to the lower surface. In other words, the pore size of the membrane 12 decreases from the upper surface to the lower surface. Typically, the pores at the upper surface have a diameter of between 30 pm and 40 pm, advantageously 35 pm, while the pores at the lower surface have a diameter of between 2 pm and 3 pm, typically 2.5 pm.
[0041] The membrane 12 is preferably made of a hydrophilic material, preferably a hydrophilic polymer having no affinity with proteins. The membrane 12 can advantageously trap up to 50 pL of whole blood per cm2.
[0042] Advantageously, the membrane is composed of two hydrophilic sub-membranes: an asymmetric membrane for trapping blood cells and a collection membrane.
[0043] The membrane 12 is preferably in the form of a disc with a diameter of between 0.5 cm and 2 cm, typically 1.4 cm. Alternatively, the membrane 12 may take any other shape, such as a polygonal, square or rectangular shape.
[0044] The membrane 12 makes it possible to obtain a plasma comprising a quantity of cells remaining in the plasma less than 2% of the initial quantity of cells contained in the whole blood sample.
[0045] Similarly, the amount of lysed cells is less than 2% of the initial amount of cells contained in the blood sample.
[0046] Advantageously, the membrane 12 comprises a front edge 21 and a rear edge 22. The membrane 12 is positioned inclined at an angle of between 5° and 10° from the front edge 21 towards the rear edge 22 relative to a longitudinal plane of the capillary 13. Capillary 13
[0047] The capillary 13 as illustrated in [Fig.l] extends from the inlet 31 to the outlet 17. The path of the capillary can adopt different shapes, such as a rectilinear or curved path or even a serpentine shape in order to optimize the space occupied by the capillary 13 on the cartridge 11.
[0048] The capillary 13 may be formed by a material removal process such as etching, or by a material deposition process such as 3D printing in order to form the walls of the capillary 13, or by molding in the cartridge 11, then closing with a transparent cover.
[0049] The inlet 31 of the capillary 13 is positioned so as to receive the filtered plasma obtained at the lower surface of the membrane 12. Advantageously, the inlet 31 of the capillary 13 can be connected to a reservoir 32, illustrated in [Fig.2], positioned under the membrane 12 and configured to receive the filtered plasma obtained at the lower surface of the membrane 12. Typically, the reservoir 32 can have a circular shape of the same diameter as the membrane 12 and having a depth of between 100pm and 200pm. Advantageously, the capacity of the reservoir is between 5pL and 100pL, and preferably less than 8pL.
[0050] The capillary 13 can have a circular section or a polygonal section.In the embodiment shown, the capillary 13 has a rectangular section and has a capillary bottom, two capillary lateral surfaces extending opposite each other from the capillary bottom and a capillary upper surface extending between the capillary lateral surfaces opposite the capillary bottom. For example, the capillary 13 has a height, between the capillary bottom and the capillary upper surface, of between 100 pm and 200 pm, preferably less than 150 pm. The width of the section of the capillary 13, between the capillary lateral surfaces, is between 1 mm and 3 mm. The length of the portion of the capillary 13 defined between the T-junction 14 and the outlet 17 is chosen according to the volume that it is desired to deliver at the outlet. This volume can be between 5 μL and 15 μL, typically 8 μL, 10 μL, 12 μL or 14 μL. Typically, the length of the capillary 13 is between 2cm and 10cm.
[0051] The choice of the material of the capillary 13 is also important, because it makes it possible to limit the travel time of the plasma within the capillary 13. Thus, the capillary 13 is preferably made of a material having a wetting angle of less than 60°, preferably less than 57° with the plasma. Typically, a material such as acrylic can be used for the walls of the capillary 13.
[0052] The outlet 17 of the capillary can take several forms. Generally, the shape of the outlet 17 is chosen so as to allow contact between the plasma contained in the capillary 13 and an absorbent surface belonging, for example, to a device for testing a given biological marker. For this purpose, the edge of the cartridge 11 comprising the outlet 17 has a triangular shape in order to minimize the contact of said edge with the absorbent surface. Ejection organ 18
[0053] The ejection member 18 according to the invention can take different forms. Typically, the ejection member 18 can comprise an actuating element 16 and a channel 15 connecting the actuating element to the capillary 13. In the embodiment, the actuating element 16 is in the form of a button made of one or more layers of deformable material so as to have a convexity, and made integral with the upper surface of the cartridge 11, typically by welding. The channel 15 has a channel bottom, two channel side surfaces extending opposite each other from the channel bottom, and a channel top surface extending between the channel side surfaces opposite the channel bottom. Thus, a user can press the button so as to deform it and expel the fluid contained within the button into the channel 15.
[0054] Typically, the button material is an elastically deformable polymer or a deformable aluminum component.
[0055] The volume of fluid contained in the button is at least three times greater than the volume of plasma that is to be ejected. Thus, for example, the volume of fluid contained in the button is 15 pL to 60 pL.
[0056] Conventionally, the fluid used is air but it is also possible to choose a fluid that is immiscible with the plasma, such as an oil.
[0057] Alternatively, the ejection member 18 can be any source of fluid that can be activated by the user, such as an injection bulb, a syringe, or the like. T-junction
[0058] As illustrated in [Fig. 3], the channel 15 is connected to the capillary 13 so as to form an angle substantially equal to 90° so as to form a T-junction 14. The channel 15 has a first widened section 61 having a height of between 150 pm and 1 mm and a width of between 2 mm and 3 mm, as well as a second widened section 62 having a height of between 150 pm and 1 mm and a width of between 2 mm and 3 mm opening directly into the capillary 13. The second widened section 62 defines a first volume 63 and the area of the capillary 13 adjoining the second widened section 62 defines a second volume 64. The invention aims to minimize these two volumes 63, 64 to a volume less than 0.2% of the volume of plasma that it is desired to deliver at the outlet of the device 100.Indeed, these two volumes 63, 64 are responsible for the variability of the volume of plasma delivered at the outlet of the device because the plasma contained in these two volumes 63, 64 can migrate towards the membrane 12 or the outlet 17 under the effect of the injection of fluid from the ejection member 18. Method of manufacturing the device.
[0059] The device can be manufactured in several ways. According to a first embodiment, the device can be obtained by photolithography. This method comprises steps of exposing a photosensitive resin covered by masks having in particular the shape of the capillary to UV light in order to solidify the resin.
[0060] Alternatively, the device may be obtained by a diffusion welding method, so as to weld together a set of acrylic layers comprising the different parts of the device 100.
[0061] Thus, as illustrated in [Fig.2], the device 100 may consist of a superposition of different layers secured to each other, for example by welding. The layers have the same outline, in particular rectangular, and identical dimensions. In the embodiment shown, the device 100 may comprise: - a support layer 51 having the shape of the cartridge 11 and comprising the capillary bottom and the channel bottom, - a first layer 52 comprising the lateral capillary surfaces and the lateral channel surfaces so as to define their outlines, the first layer 52 also comprising, in the embodiment shown, the reservoir 32, - a second layer 53 comprising the upper surfaces of the capillary and channel, a first location 55 configured to receive the membrane 12 and a second location 54 configured to receive the actuating element 16 of the ejection member 18.
[0062] The thickness of the second acrylic layer 53 may vary according to its length so as to allow inclined positioning of the membrane 12. Alternatively, an additional layer, not shown, may be added to the second layer 53 in order to create an excess thickness allowing the membrane 12 to be inclined. Finally, the membrane 12 is positioned in the first location 55 of the second layer 53, while the actuating element 16 of the ejection member 18 is positioned in the second location 54 of the second layer 53.
[0063] Alternatively, the device 100 can for example be obtained by 3D printing.
[0064] In the embodiment shown, the layers of the device 100 are made of acrylic and more specifically of poly(methyl methacrylate) or PMMA. In other embodiments, the layers could be made of any suitable material and in particular of an epoxy polymer, such as copper. Method 200
[0065] As illustrated in [Fig.4], the invention also relates to a method 200 for extracting plasma from a blood sample via a device 100 as described previously.
[0066] The first step 201 of the method 200 consists of depositing a blood sample on the membrane 12 so as to obtain plasma in the capillary 13. To do this, the blood sample is applied to the upper surface of the membrane 12. The blood can be applied in the form of a drop, by means of a disposable pipette or even directly by placing the finger previously pierced by a microneedle directly on the membrane. A volume of blood between 50 pL and 100 pL, preferably 80 pL, can be deposited on the membrane 12.
[0067] As blood migrates across membrane 12, all blood cells are gradually trapped in the pore labyrinth and the plasma is allowed to flow through the lower surface of the membrane 12 to be collected in the reservoir 32. The driving force of the separation process is capillarity.
[0068] The plasma then flows into the capillary 13 until it completely fills the portion of the capillary 13 located between the T-junction 14 and the outlet 17.
[0069] The second step 202 then consists of actuating the ejection member 18 to eject the volume of plasma between the T-junction 14 and the outlet 17, through said outlet 17.
[0070] Advantageously, the time between the deposition of the whole blood sample on the membrane 12 and the moment when the plasma can be delivered, that is to say when the portion of the capillary between the T-junction 14 and the outlet 17 is filled, is between 1 and 5 minutes.
Claims
Claims
1. A device (100) for extracting plasma from a blood sample, the extraction device (100) comprising: - a membrane (12) configured to extract the plasma from the blood sample, the membrane (12) having an upper surface arranged to receive the blood sample and a lower surface, - a capillary (13) comprising: an inlet (31) arranged opposite the lower surface of the membrane (12) to receive the plasma, and an outlet (17) open to an exterior of the extraction device, the capillary (13) being configured to transport the plasma from the inlet (31) to the outlet (17) along a trajectory, - an ejection member (18) actuable by an operator and configured to eject a volume of plasma located in the capillary (13) through the outlet (17) when said ejection member (18) is actuated,the extraction device (100) further comprising a T-junction (14) to which the ejection member (18) is connected, perpendicular to the capillary (13), the plasma volume being between the T-junction (14) and the outlet (17).,
2. An extraction device (100) according to claim 1, wherein the membrane (12) has a leading edge and a trailing edge, the membrane (12) being inclined at an angle of between 5° and 10° from the leading edge to the trailing edge relative to a longitudinal plane of the capillary (13).
3. Extraction device (100) according to claim 1 or 2, wherein the capillary (13) is made of a material having a wetting angle of less than 60°, preferably less than 57° with the plasma.
4. Extraction device (100) according to one of claims 1 to 3, in which the capillary (13) has a defined height between the inlet and the outlet of less than 150 pm.
5. Extraction device (100) according to one of claims 1 to 4, wherein the ejection member (18) is configured to supply a volume of fluid into the capillary (13) at the T-junction (14).
6. The extraction device (100) of claim 5, wherein the volume of fluid is at least three times the volume of plasma.
7. Extraction device (100) according to one of claims 5 or 6, in which the fluid is air.
8. Extraction device (100) according to one of claims 1 to 7, in which the ejection member (18) comprises a deformable element, actuable by finger.
9. Extraction device (100) according to one of claims 1 to 8, wherein the T-junction (14) has a volume less than 0.2% of the plasma volume.
10. Extraction device (100) according to one of claims 1 to 9, wherein the capillary (13) has a capillary bottom, two capillary lateral surfaces extending opposite each other from the capillary bottom and a capillary upper surface extending between the capillary lateral surfaces opposite the capillary bottom, and wherein the ejection member (18) comprises an actuating element (16) and a channel (15) having a channel bottom, two channel lateral surfaces extending opposite each other from the channel bottom and a channel upper surface extending between the channel lateral surfaces opposite the channel bottom, the extraction device (100) consisting of at least: - a support layer (51) comprising the capillary bottom and the channel bottom,- a first layer (52) superimposed on the support layer (51) and comprising the lateral surfaces of the capillary and the lateral surfaces of the channel, - a second layer (53) superimposed on the first layer (52) and comprising the upper surfaces of the capillary and the channel, a first location (55) configured to receive the membrane (12) and a second location (54) configured to receive the actuating element (16) of the ejection member (18).,
11. Method for extracting plasma from a blood sample via a device according to one of claims 1 to 10, the method comprising the steps of: - depositing a blood sample on the membrane (12) so as to obtain plasma in the capillary (13), - actuating the ejection member (18) to eject a volume of plasma located in the capillary (13) through the outlet (17) when said ejection member is actuated, the volume of plasma being between the T-junction (14) and the outlet (17).
12. The method of claim 11, wherein the method comprises a step of positioning the outlet (17) of the device in direct contact with an absorbent surface.
Citation Information
Patent Citations
Micro filtration device for separation of blood plasma, which prevents efficiency of separating blood plasma from being lowered
KR1020080051011A
Device and method for separating a fluid mixture such as blood
US10670579B2
Device and Method for Collecting Plasma
US20190374938A1
Capillary system for a blood separation device
WO2020160616A1
